Baim Institute for Clinical Research

Join more distinguished Baim faculty tomorrow on the last day of #TCT2024! 🫀✨Baim faculty participating in discussions and presentations: Dr. Donald Cutlip, Ori Ben-Yehuda, Sunil Rao, Professor Vijay Kunadian, Malissa Wood, Harold Dauerman, Rahul Sharma, Rasha Al-Lamee Dr. Dominick Angiolillo, Dr. Shamir Mehta, Dr. Roger J. Laham, & Saibal Kar! #interventionalcardiology #HeartHealth #Cardiology Continue reading for details on the lectures given by our faculty on the last day of #TCT2024! 🌟 Be sure to attend Ori Ben-Yehuda’s lecture "CV Event Reduction is the Essential Criterion for Implementing New Device Therapies" at 11:34am on Day 4 of #TCT2024! 🌟 Join Dr. Donald Cutlip for his lecture "REC/CAGE FREE" at 2:34pm on Day 4 of #TCT2024! 🌟 Don't miss Saibal Kar at his lecture "One-Year Follow-Up of the US Early Feasibility Study Evaluating Rotational Closure of the LAA Using the Laminar Device" at 10:38am on Day 4 of #TCT2024! 🌟 Connect with Harold Dauerman at his lecture "The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps" at 8:40am on Day 4 of #TCT2024!

Don't miss more Baim faculty presenting and leading discussions tomorrow at Day 3 of #TCT2024! 🫀👍Baim faculty participating tomorrow: Dr. Donald Cutlip, Clyde Yancy, Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, Dr. Suzanne J. Baron, Sunil Rao, Robert Yeh, Pascal Vranckx, M Cecilia Bahit, Professor Vijay Kunadian, Kevin Bainey, Wally Omar, Harold Dauerman, Rahul Sharma, Dr. Dominick Angiolillo, Dr. Shamir Mehta, Dr. Roger J. Laham, and Saibal Kar! #interventionalcardiology #hearthealth Continue reading for details on the lectures given by our faculty on Day 3 of #TCT2024! 🌟 Don't miss Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM for his lectures "Real World Data in PAD" at 8 am, "Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!" at 5:08pm, and "What am I Most Anticipating in Upcoming Clinical Trials?" at 5:34pm on Day 3 of #TCT2024! 🌟 Join Robert Yeh for his lecture "Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB" at 10am on Day 3 of #TCT2024! 🌟 Be sure to check out Dr. Shamir Mehta's lecture "Increasingly Complex ACS Patients: Culprit Only, Complete Percutaneous Revascularization or CABG?" at 7:58am on Day 3 of #TCT2024! 🌟 Connect with Saibal Kar at his lectures "Transcatheter Management" at 8:15am and "M-TEER in SMR: Device Selection, Procedural Considerations, and How to Define Success" at 4:08pm on Day 3 of #TCT2024!

Join our esteemed Baim faculty tomorrow at Day 2 of #TCT2024 as they lead thoughtful discussions and presentations! 👏 Baim faculty participating tomorrow: C. Michael Gibson, M.S., M.D., Dr. Donald Cutlip, Javed Butler, Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, Dr. Suzanne J. Baron, Sunil Rao, Robert Yeh, Pascal Vranckx, M Cecilia Bahit, Professor Vijay Kunadian, Kevin Bainey, Rasha Al-Lamee, Dr. Dominick Angiolillo, Dr. Shamir Mehta, Dr. Roger J. Laham, and Saibal Kar! #interventionalcardiology Continue reading for details on the lectures given by our faculty on Day 2 of #TCT2024! 🌟 Don't miss C. Michael Gibson, M.S., M.D. for his lecture "Diabetes and Obesity: Modulating Cardiometabolic Risks" at 9:10am and his lecture "What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS" at 4:21pm on Day 2 of #TCT2024! 🌟 Join Javed Butler for his lecture "Modern GDMT for HFrEF: Great but Significant Residual Risks Remain" at 3:40pm and his lecture "Interatrial Shunts (IASD): From Theory to Clinical Trials" at 4:50pm on Day 2 of #TCT2024! 🌟 Come see Robert Yeh for his lecture "How Far Can We Push Observational Data to Answer Clinical Questions: Statistical Considerations" at 5:38pm on Day 2 of #TCT2024! 🌟 Join Professor Vijay Kunadian for her lecture "Inflammation: The Next Frontier" at 9:25am on Day 2 of #TCT2024! 🌟 Don't miss Kevin Bainey for his lecture "What Comes Next? Role of Inflammation on AMI" at 11:27am on Day 2 of #TCT2024! 🌟 Come see Rasha Al-Lamee for her lecture "Coronary Microvascular Disease -- How Do We Move the Field Forward?" at 9:10am on Day 2 of #TCT2024! 🌟 Connect with Dr. Dominick Angiolillo at his lecture "Optimal Anti-Thrombotic Therapy in Acute MI" at 9:08am on Day 2 of #TCT2024!

This past week we had our End of Summer Employee outing! It was nothing short of fun, as we went canoeing and kayaking on the Charles River in Boston, played fun games, and enjoyed a barbecue lunch all together! We are already looking forward to the next outing.

When is a right time to lead from the front?   Nelson Mandela famously recommended “you take the frontline when there is danger.”   Until joining Amgen over two years ago, I hadn’t thought nearly enough about my LDL or “bad” cholesterol, despite it being one of the most impactful modifiable risk factors for cardiovascular disease.   During the last couple of years, it has been a privilege to drive LDL-C awareness and action with colleagues from organizations including American College of Cardiology, American Heart Association, Family Heart Foundation, National Lipid Association, Baim Institute for Clinical Research, Cardiometabolic Center Alliance, Duke Clinical Research Institute driven by the shared heartfelt desire to make a meaningful impact on heart disease.    These wonderful colleagues inspired me to take action on my own LDL-C and join the #CheckLDL testing challenge.  Proud to have brought it down to American College of Cardiology recommendations working with my doctor! Do you know your LDL-C? If not, please get tested this #cholesterolmonth.     Proud of my Amgen colleagues who have worked tirelessly to expand our no cost cholesterol testing program. Visit https://amgen.ly/checkldl to get more info on how to get a free LDL-C test. Be sure to talk to your doctor about your results.    There’s no better time to lead from the front! #MyCompany

Feeling inspired about the future of cardiovascular care following the LDL-C Action Summit and LATTICE™ Consortium meetings at European Society of Cardiology’s #ESCCongress, which provided opportunities to reflect on the collective force of Amgen and each participating organization. These numbers tell a powerful story of the incredible progress we’ve made in over a year. Together, we are paving the way for a healthier tomorrow as we continue to drive innovation and pursue our bold ambition to halve the number of heart attacks and strokes in the U.S. by 2030.    Thank you American College of Cardiology, American Heart Association, Family Heart Foundation, National Lipid Association, Baim Institute for Clinical Research, Partnership To Advance Cardiovascular Health, National Forum for Heart Disease & Stroke Prevention, WomenHeart: The National Coalition for Women with Heart Disease, Quest Diagnostics, Kaiser Permanente, Stanford University School of Medicine, Duke Clinical Research Institute, University of Colorado School of Medicine, Yale School of Medicine, Summa Health, Cardiometabolic Center Alliance, Brigham and Women's Hospital, Harvard Medical School for your unwavering dedication to improving patient care and your focus on bending the curve in cardiovascular disease. #MyCompany

The Baim Institute is proud to announce that Dr. James Januzzi (Chief Scientific Officer) has been selected as the inaugural incumbent of the C. Michael Gibson Chair of Medicine at the Baim Institute for Clinical Research. Dr. Januzzi is a world renowned clinical trialist, biomarker expert, and clinician in cardiology, whose contributions have improved the care of patients with heart failure worldwide. He is presently the Adolph Hutter Professor of Medicine at Harvard Medical School, and will now assume the role of the Gibson Chair at the Baim Institute.

Our impressive Baim Faculty are attending, presenting, and enjoying the CRT Meetings in Washington, DC! #CRT2024 Baim Institute is a full-service Academic Research Organization. Reach out to us for your clinical trial needs at https://lnkd.in/d58Yj7yR or mayme.roettig@baiminstitute.org.

Baim Institute for Clinical Research (formerly HCRI) is attending THT in Boston March 4-6th! We are an Academic Research Organization providing full trial services with enormous device and pharma experience. Currently Baim is working on studies with 100,000+ study participants in >125 clinical trials (22 full service/academic leadership; 35 imaging core laboratory; 44 CEC and 24 DSMC).  Our CEO (Dr. C. Michael Gibson, M.S., M.D.), CMO (Dr. Don Cutlip) and our Director of HF and Biomarkers (Dr. James Januzzi) will be attending. To set up a meeting with one of our faculty members to discuss your study needs, please reach out to Mayme Lou Roettig to arrange (mayme.roettig@baiminstitute.org)! We look forward to a great meeting! #THT24

Happy New Year! From our family to yours!